AME Company for Medical Supplies Announces the Results of the Ordinary General Assembly Meeting (First Meeting)

Element List	Explanation
Introduction	AME Company for Medical Supplies announces the results of the Ordinary General Assembly meeting (first meeting) which was held at 7:00 PM on Monday, 14 Muharram 1448 AH, corresponding to June 29, 2026 AD, via modern technology to discuss the meeting items after the legal quorum for the meeting was completed.
City and Location of the General Assembly's Meeting	The company's headquarters in Jeddah (in person) using modern technology (remotely) via the Tadawulati platform
Date of the General Assembly's Meeting	2026-06-29 Corresponding to 1448-01-14
Time of the General Assembly’s Meeting	19:00
Percentage of Attending Shareholders	57.34%
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees	The meeting was attended by the following members of the Board of Directors: Mr. Faisal Mohammed Alomran – Chairman of the Board (Non-Executive Director) Dr. Ali Mohammeddeeb Eed – Managing Director and Board Member (Executive Director) Ms. Latifah Abdulrahman Alhudaib – Board Member (Independent Director) Mr. Khalid Saeed Alsefri – Board Member (Independent Director) Mr. Abdulaziz Saleh Alomair – Vice Chairman of the Board (Non-Executive Director), was absent from the meeting.
Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf	Mr. Saleh Abdullah AlQuraisha – Chairman of the Audit Committee Ms. Latifah Abdulrahman Alhudaib – Chairwoman of the NRC
Voting Results on the Items of the General Assembly's Meeting Agenda's	The voting results were as follows: 1. The Board of Directors’ Report for the financial year ended 31 December 2025 was reviewed. 2. The Financial Statements for the financial year ended 31 December 2025 were reviewed. 3. Approval of the External Auditor’s Report for the financial year ended 31 December 2025. 4. Approval of the discharge of liability of the members of the Board of Directors for the financial year 2025. 5. Approval of the Board of Directors’ recommendation to distribute cash dividends amounting to SAR 14,000,000 (Fourteen Million Saudi Riyals) to shareholders for the financial year ended 31 December 2025, at SAR 2.00 per share, representing 20% of the Company's share capital. Eligibility for the dividends shall be limited to shareholders who own the shares at the close of trading on the date of the General Assembly meeting and who are registered in the Company’s shareholders’ register maintained by the Securities Depository Center Company (Edaa) at the end of the second trading day following the eligibility date. Dividend payments shall commence on 14 July 2026 through direct transfer to the bank accounts linked to the investment portfolios of the eligible shareholders. 6. Approval of the payment of Board of Directors’ remuneration amounting to SAR 853,333.64 for the financial year ended 31 December 2025. 7. Approval of the amendments to the Board of Directors’ Remuneration Policy. 8. Approval of the Board of Directors Charter. 9. Approval of the amendments to the Audit Committee Charter. 10. Approval of the Nomination and Remuneration Committee Charter.
Additional Information	If you have any questions, please contact the Investor Relations Department via email at: investor.relations@ame.med.sa